A Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a multicentre, open-label phase Ib/II study. The purpose of the study is to assess the efficacy, safety/ tolerability and pharmacokinetic of GFH009 monotherapy in patients with relapsed or refractory peripheral T-cell lymphoma
Epistemonikos ID: 4fd46989a3599c83fece95646b64e1fbe6753605
First added on: May 15, 2024